Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors
June 22nd, 2020 by Pabitra K. Parua
Nature Chemical Biology, Published online: 22 June 2020; doi:10.1038/s41589-020-0563-4
This Review provides insights into transcriptional regulation, and vulnerabilities of cancer cells to disruption of cyclin-dependent kinase (CDK)-mediated regulation of Pol II transcription, revealed with small-molecule CDK inhibitors.